Gauthier Pouliquen
8Patents
4h-index
17Co-inventors
50Inventor score
Filing activity: Nov 19, 2004 → Nov 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8084045B2 | Pharmaceutical formulations for the prolonged release of active principle(s) and their applications | Human Necessities | 35 | Active |
| US10052289B2 | Composition comprising an active agent with low aqueous solubility | Human Necessities | 34 | Active |
| US10493051B1 | Cysteine composition and injection | Human Necessities | 20 | Active |
| US10543186B1 | Cysteine composition and injection | Human Necessities | 18 | Active |
| US10702490B1 | Cysteine composition and injection | Human Necessities | 0 | Active |
| US9272020B2 | IFN-beta compositions, preparation methods and uses thereof | Human Necessities | 0 | Active |
| US8206744B2 | Branched polyamino acids functionalized with hydrophobic groups, and applications thereof particularly therapeutic applications | Human Necessities | 0 | Active |
| US11045438B2 | Cysteine composition and injection | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.